ACADIA Pharmaceuticals Inc. (ACAD) NASDAQ
20.92
-0.6(-2.79%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
20.92
-0.6(-2.79%)
Currency In USD
| Market Cap | 4.52B |
| Enterprise Value | 4.4B |
| P/E Ratio | 9.5 |
| PEG Ratio | 0.15 |
| Price/Sales Ratio | 3.27 |
| Price/Book Ratio | 2.86 |
| Enterprise/Revenue | 3.06 |
| Enterprise/EBITDA | 32.05 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.34 |
| Operating Margin | 0.07 |
| Return On Assets | 0.23 |
| Return On Equity | 0.36 |
| Revenue | 1.07B |
| Revenue/Share | 6.42 |
| Gross Profit | 982.51M |
| EBITDA | 138.9M |
| Net Income | 391M |
| Diluted EPS | 2.29 |
| Total Cash | 851.46M |
| Total Cash/Share | 4.99 |
| Total Debt | 50.79M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 3.59 |
| Book Value Per Share | 7.32 |
| 52-Week Change | -2.56 |
| 52-Week High | 28.35 |
| 52-Week Low | 19.69 |
| Moving Average 50 Days | 21.77 |
| Moving Average 200 Days | 23.55 |
| Average Volume | 1.79M |
| Shares Outstanding | 171.24M |
| % Held by Institutions | 97.29 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |